Par Drugs & Chemicals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 27.88 | 23.12 | 21.65 |
| Operating Expense | 22.49 | 19.90 | 19.95 |
| Net Profit | 3.33 | 1.65 | 0.58 |
| Net Profit Margin | 11.94 | 7.14 | 2.68 |
| Earning Per Share | 2.70 | 1.34 | 0.47 |
| EBIDTA | 5.40 | 3.18 | 1.69 |
| Effective Tax Rate | 21.30 | 18.32 | 11.18 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 27.88 |
| Operating Expense | 22.49 |
| Net Profit | 3.33 |
| Net Profit Margin | 11.94 |
| Earning Per Share | 2.70 |
| EBIDTA | 5.40 |
| Effective Tax Rate | 21.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 100.97 | 95.64 | 95.75 |
| Operating Expenses Annual | 81.47 | 72.82 | 77.54 |
| Operating Profit Annual | 21.65 | 23.06 | 18.45 |
| Interest Annual | 0.08 | 0.11 | 0.13 |
| Depreciation | 3.65 | 3.44 | 3.23 |
| Net Profit Annual | 13.36 | 14.50 | 11.33 |
| Tax Annual | 4.57 | 5.02 | 3.75 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 100.97 |
| Operating Expenses Annual | 81.47 |
| Operating Profit Annual | 21.65 |
| Interest Annual | 0.08 |
| Depreciation | 3.65 |
| Net Profit Annual | 13.36 |
| Tax Annual | 4.57 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 36.65 | 22.24 | 16.21 |
| Cash Flow from Operations | 16.16 | 20.25 | 13.38 |
| Cash Flow from Investing | -25.24 | -5.84 | -7.34 |
| Cash Flow from Financing | TBA | TBA | TBA |
| Cash Flow at the End | 27.58 | 36.65 | 22.24 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 36.65 |
| Cash Flow from Operations | 16.16 |
| Cash Flow from Investing | -25.24 |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | 27.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 19.09 | 21.50 | 19.26 |
| PBIT Margin (%) | 15.87 | 18.29 | 15.89 |
| PBT Margin (%) | -182.67 | -148.08 | -106.30 |
| Net PROFIT Margin (%) | 11.78 | 13.52 | 11.83 |
| Return On Networth / Equity (%) | 14.47 | 18.49 | 17.28 |
| Return On Networth /Employed (%) | 19.48 | 25.01 | 23.11 |
| Return On Assets (%) | 14.49 | 18.52 | 17.16 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 1.23 | 1.37 | 1.45 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 19.09 |
| PBIT Margin (%) | 15.87 |
| PBT Margin (%) | -182.67 |
| Net PROFIT Margin (%) | 11.78 |
| Return On Networth / Equity (%) | 14.47 |
| Return On Networth /Employed (%) | 19.48 |
| Return On Assets (%) | 14.49 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 1.23 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 38.91 | 41.31 | 38.45 |
| Total Current Assets Annual | 54.86 | 59.62 | 49.44 |
| Non Current Assets Annual | 64.53 | 41.99 | 39.43 |
| Total Shareholders Funds Annual | 98.97 | 85.63 | 71.24 |
| Total Assets Annual | 119.39 | 101.61 | 88.87 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 38.91 |
| Total Current Assets Annual | 54.86 |
| Non Current Assets Annual | 64.53 |
| Total Shareholders Funds Annual | 98.97 |
| Total Assets Annual | 119.39 |
No Data Availabe
